
Metabolic Reprogramming for Senescent-Cell Biology
Our Cor-Technology represents a next-generation, evidence-based approach to the metabolic reprogramming of senescence-driven cellular dysfunction. CorTech is the only naturally occurring compound identified in this plant that has demonstrated the ability to direct bioactive into cellular organelles, including the mitochondria. Scientific data demonstrate that CorTech supports mitochondrial cellular energy synthesis and drives mitochondrial metabolic reprogramming through a novel metabolic-switch mechanism. This mechanism reduces cellular reliance on glycolysis, promotes fatty-acid oxidation, and modulates key cellular signaling, epigenetic-regulatory, and proliferation-related pathways.
This scientifically validated and differentiated platform creates evidence-based opportunities across pharmaceuticals, nutraceuticals, dietary supplements, functional wellness, healthy aging, and the emerging cellular beauty market—serving the expanding global healthcare, wellness, beauty, and life-science sectors.


HOW IT WORKS

Targeting Personalized Biomarker
Mitochondrial Voltage
for Eradicating Cancer
and Preventing Relapse


OUR MISSION & VISION
We seek strategic partners to evaluate, license, and co-develop Cor-Technology, a novel metabolic-reprogramming platform for senescent-cell biology. Protected by a provisional patent application and supported by an expanding IP strategy, the platform enables customized research and product-development opportunities across pharmaceutical, wellness, healthy-aging, and cellular-beauty markets.
